Table 1 Baseline characteristics of patients with primary malignant melanoma of esophagus
Total (n = 17) | |
|---|---|
Age (years) | |
Mean ± SD | 61.0 ± 12.3 |
Median (range) | 60 (41–83) |
Sex (%) | |
Male | 15 (88.2) |
Female | 2 (11.8) |
Chief complaint (%) | |
Dysphagia | 9 (52.9) |
Epigastric discomfort | 2 (11.8) |
Chest pain | 1 (5.9) |
Dyspepsia | 1 (5.9) |
Nausea | 1 (5.9) |
Weight loss | 1 (5.9) |
No symptom | 2 (11.8) |
Smoking (%) | |
No | 9 (52.9) |
Yes | 8 (47.1) |
Alcohol ingestion (%) | |
No | 6 (35.3%) |
Yes | 11 (64.7%) |
BMI (kg/m2) | |
Mean ± SD | 23.8 ± 2.6 |
Median (range) | 23.7 (19–30) |
Endoscopic morphology (%) | |
Mass-forming | 15 (88.2) |
Diffusely infiltrative | 2 (11.8) |
Amelanotic type (%) | |
No | 13 (76.5) |
Yes | 4 (23.5) |
Endoscopic size* (cm) | |
Mean ± SD | 4.8 ± 2.2 |
Median (range) | 5.0 (2–10) |
Endoscopic location (%) | |
Upper | 3 (17.6) |
Middle | 3 (17.6) |
Lower | 11 (64.7) |
Clinical staging (%) | |
Localized (N0) | 8 (47.1) |
Node positive (N+) | 5 (29.4) |
Metastatic (M1) | 4 (23.5) |
Surgery (%) | |
No | 5 (29.4) |
Yes | 10 (58.8) |
Follow-up loss | 2 (11.8) |